Heme-induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease

Standard

Heme-induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease. / Chen, Grace; Zhang, Dachuan; Fuchs, Tobias A; Manwani, Deepa; Wagner, Denisa D; Frenette, Paul S.

in: BLOOD, Jahrgang 123, Nr. 24, 12.06.2014, S. 3818-27.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Chen, G, Zhang, D, Fuchs, TA, Manwani, D, Wagner, DD & Frenette, PS 2014, 'Heme-induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease', BLOOD, Jg. 123, Nr. 24, S. 3818-27. https://doi.org/10.1182/blood-2013-10-529982

APA

Chen, G., Zhang, D., Fuchs, T. A., Manwani, D., Wagner, D. D., & Frenette, P. S. (2014). Heme-induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease. BLOOD, 123(24), 3818-27. https://doi.org/10.1182/blood-2013-10-529982

Vancouver

Bibtex

@article{61de5743f1434ad198955662dc3f07b4,
title = "Heme-induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease",
abstract = "Sickle cell disease (SCD) is characterized by recurring episodes of vascular occlusion in which neutrophil activation plays a major role. The disease is associated with chronic hemolysis with elevated cell-free hemoglobin and heme. The ensuing depletion of heme scavenger proteins leads to nonspecific heme uptake and heme-catalyzed generation of reactive oxygen species. Here, we have identified a novel role for heme in the induction of neutrophil extracellular trap (NET) formation in SCD. NETs are decondensed chromatin decorated by granular enzymes and are released by activated neutrophils. In humanized SCD mice, we have detected NETs in the lungs and soluble NET components in plasma. The presence of NETs was associated with hypothermia and death of these mice, which could be prevented and delayed, respectively, by dismantling NETs with DNase I treatment. We have identified heme as the plasma factor that stimulates neutrophils to release NETs in vitro and in vivo. Increasing or decreasing plasma heme concentrations can induce or prevent, respectively, in vivo NET formation, indicating that heme plays a crucial role in stimulating NET release in SCD. Our results thus suggest that NETs significantly contribute to SCD pathogenesis and can serve as a therapeutic target for treating SCD.",
author = "Grace Chen and Dachuan Zhang and Fuchs, {Tobias A} and Deepa Manwani and Wagner, {Denisa D} and Frenette, {Paul S}",
note = "{\textcopyright} 2014 by The American Society of Hematology.",
year = "2014",
month = jun,
day = "12",
doi = "10.1182/blood-2013-10-529982",
language = "English",
volume = "123",
pages = "3818--27",
journal = "BLOOD",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "24",

}

RIS

TY - JOUR

T1 - Heme-induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease

AU - Chen, Grace

AU - Zhang, Dachuan

AU - Fuchs, Tobias A

AU - Manwani, Deepa

AU - Wagner, Denisa D

AU - Frenette, Paul S

N1 - © 2014 by The American Society of Hematology.

PY - 2014/6/12

Y1 - 2014/6/12

N2 - Sickle cell disease (SCD) is characterized by recurring episodes of vascular occlusion in which neutrophil activation plays a major role. The disease is associated with chronic hemolysis with elevated cell-free hemoglobin and heme. The ensuing depletion of heme scavenger proteins leads to nonspecific heme uptake and heme-catalyzed generation of reactive oxygen species. Here, we have identified a novel role for heme in the induction of neutrophil extracellular trap (NET) formation in SCD. NETs are decondensed chromatin decorated by granular enzymes and are released by activated neutrophils. In humanized SCD mice, we have detected NETs in the lungs and soluble NET components in plasma. The presence of NETs was associated with hypothermia and death of these mice, which could be prevented and delayed, respectively, by dismantling NETs with DNase I treatment. We have identified heme as the plasma factor that stimulates neutrophils to release NETs in vitro and in vivo. Increasing or decreasing plasma heme concentrations can induce or prevent, respectively, in vivo NET formation, indicating that heme plays a crucial role in stimulating NET release in SCD. Our results thus suggest that NETs significantly contribute to SCD pathogenesis and can serve as a therapeutic target for treating SCD.

AB - Sickle cell disease (SCD) is characterized by recurring episodes of vascular occlusion in which neutrophil activation plays a major role. The disease is associated with chronic hemolysis with elevated cell-free hemoglobin and heme. The ensuing depletion of heme scavenger proteins leads to nonspecific heme uptake and heme-catalyzed generation of reactive oxygen species. Here, we have identified a novel role for heme in the induction of neutrophil extracellular trap (NET) formation in SCD. NETs are decondensed chromatin decorated by granular enzymes and are released by activated neutrophils. In humanized SCD mice, we have detected NETs in the lungs and soluble NET components in plasma. The presence of NETs was associated with hypothermia and death of these mice, which could be prevented and delayed, respectively, by dismantling NETs with DNase I treatment. We have identified heme as the plasma factor that stimulates neutrophils to release NETs in vitro and in vivo. Increasing or decreasing plasma heme concentrations can induce or prevent, respectively, in vivo NET formation, indicating that heme plays a crucial role in stimulating NET release in SCD. Our results thus suggest that NETs significantly contribute to SCD pathogenesis and can serve as a therapeutic target for treating SCD.

U2 - 10.1182/blood-2013-10-529982

DO - 10.1182/blood-2013-10-529982

M3 - SCORING: Journal article

C2 - 24620350

VL - 123

SP - 3818

EP - 3827

JO - BLOOD

JF - BLOOD

SN - 0006-4971

IS - 24

ER -